(Q34528467)

2 August 2017

title

Investigation of auranofin-induced diarrhoea (English)

1 reference

2 August 2017

0 references

Behrens R

1

1 reference

2 August 2017

Devereaux M

2

1 reference

2 August 2017

Hazleman B

3

1 reference

2 August 2017

Szaz K

4

1 reference

2 August 2017

Calvin J

5

1 reference

2 August 2017

Neale G

6

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 January 1986

1 reference

2 August 2017

1 reference

2 August 2017

volume

27

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

59-65

1 reference

Intestinal permeability in children with Crohn's disease and coeliac disease

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1433187

Gold colitis, therapy and confirmation of mucosal recovery by measurement of rectal potential difference

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1433187

Assessment of the reproducibility of the lactulose H2 breath test as a measure of mouth to caecum transit time

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1433187

Nonexudative diarrhea after gold salt therapy: case report and review of the literature

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1433187

Measurement of the mean transit time of dietary residue through the human gut

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1433187

Auranofin. New oral gold compound for treatment of rheumatoid arthritis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1433187

Diagnosis of protein-losing enteropathy by gastrointestinal clearance of alpha1-antitrypsin

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1433187

Loose stools during auranofin treatment: clinical study and some pathogenetic possibilities.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1433187

Investigation of small bowel transit time in man utilizing pulmonary hydrogen (H2) measurements

27 October 2018

1 reference

12 December 2020

Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs

1 reference

12 December 2020

IN VIVO DIALYSIS OF FAECES AS A METHOD OF STOOL ANALYSIS. I. TECHNIQUE AND RESULTS IN NORMAL SUBJECTS

1 reference

12 December 2020

Laxative-like effects of nonsteroidal anti-inflammatory drugs on intestinal fluid movement and membrane integrity

1 reference

12 December 2020

Oral gold therapy with auranofin (SK&F 39162). A multicenter open study in patients with rheumatoid arthritis

1 reference

12 December 2020

Comparative pharmacokinetics of parenteral and oral gold compounds

1 reference

12 December 2020

A persistent defect in intestinal permeability in coeliac disease demonstrated by a 51Cr-labelled EDTA absorption test

1 reference

12 December 2020

Auranofin (SK + F 39162) induced enterocolitis in rheumatoid arthritis. A case report

1 reference

12 December 2020

Gold-induced diarrhea and the role of prostaglandins

1 reference

12 December 2020

A simple enzymatic method for the assay of urinary lactulose

1 reference

12 December 2020

Identifiers

DOI

10.1136/GUT.27.1.59

1 reference

2 August 2017

1 reference

2 August 2017

1 reference